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that individuals with T2DM are 2–4 times more likely to develop AD, but definitive 
biochemical mechanisms remain unknown.   
Aim of the study. This review has the intention to present that type 2 diabetes mellitus (T2DM) 
is a significant risk factor for cognitive dysfunction or dementia, especially those related to 
Alzheimer's disease   
Materials and methods. For the study were used electronic medical platforms such as PubMed 
Databases, Hinary and other scientific libraries like Google Scholar. It have been selected and 
analyzed 40 articles including manuscripts, reviews, and publications for the last 10 years.   
Results. Of the multiple intersection between T2DM and AD, the most pronounced is the 
insulin resistance, characterized by hyperinsulinemia and hyperglycaemia. Insulin resistance 
decreases glucose metabolism which in turn hyperphosphorylates tau protein causing 
neurofibrillary tangles. In AD, the extracellular accumulation of Aβ plaques, intracellular 
aggregation of hyperphosphorylated tau protein in neurofibrillary tangles (NFTs), and neuronal 
loss occur in the cortex and hippocampus, where are located insulin-dependent receptor GLUT 
4 and insulin-independent receptors GLUT1 and GLUT3. Receptors are affected by the 
abnormal glucose metabolism, and not only, including enzymes like GSK-3, Cdk-5, CK-1 and 
others. The mechanism of influence does not stop here; hyperglycemia can activate K-ATP 
channels that increase cellular excitability and leads to an elevated ISF Aβ. Moreover, insulin 
alteration in diabetes can interrupt brain cholesterol metabolism leading to metabolic 
dysfunction.   
Conclusions. T2DM and AD were earlier considered as two independent metabolic disorders. 
However, the present study has clearly stated the presence of common pathophysiological and 
epidemiological mechanisms, together with signaling pathways that associates a relation 
between these two pathologies. It might be possible that therapeutics for T2DM would be 
effective for AD, but in order to prove that, more investigations are needed. Recently, AD has 
been called Type 3 Diabetes.   
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Introduction.  The incidence and prevalence of tumor pathology are constantly increasing both 
globally and in our country. The implementation of new sensitive, specific and easily 
applicable methods such as tumor markers offers new possibilities in diagnosis, personalized 
treatment and subsequent monitoring.   
Aim of the study.  Presentation of the latest and most promising tumor markers according to 
the latest international studies.   
Materials and methods. It has been carried out the synthesis and analysis of the scientific 
information of the last years in the field of oncology and biomarkers. The targeted population 
studies are large and performed in the most endowed centers, with maximum truthful results. 
The markers with the best results were selected.   
Results. Liquid biopsy is an alternative to current diagnostic methods due to its sensitivity, 
applicability, rapidity and harmlessness to obtain CTC, miRNA, RNA, DNA, exosomes, 
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metabolites, etc. In the diagnosis of breast cancer, we have highlighted a number of new 
markers such as hsa_circ_0001785, lncRNA HOTAIR, GATA 3, specific plasma lipid profile 
according to tables and a large miRNA panel. Pancreatic tumors due to asymptomatic 
evolution, require screening by risk groups, therefore the new markers periostin and circ-
LDLRAD3 RNA complement CA19.9 in early diagnosis, especially in PDAC. The long known 
pyruvate-kinase M2 is determined to be effective in determining the prognosis in pancreatic 
cancer and EphA2 represents a diagnostic marker but also a therapeutic target. A number of 
metabolites are capable of differentiating chronic pancreatitis from pancreatic cancer. In the 
diagnosis of colorectal cancer, was developed a set of 16 RNAs that determine the tumor in its 
early stages. Likewise, the combination of eight serum biomarkers (CEA, CA19.9, AFP, 
Galectin3, TIMP1, ferritin, CRP, CyFra 21-1) allows efficient and rapid diagnosis.    
Conclusions.  Population studies in different countries and by different scientists have shown 
that biomarkers and biomarker panels studied allow early, rapid, specific diagnosis of the tumor 
pathologies. Diagnosis based on these tests will reduce the invasive diagnostic procedures and 
increase the survival rate due to personalized and specific treatment for each tumor. They also 
allow subsequent monitoring, relapses and prognosis.   
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Introduction. Gluten is a nutritional term used to refer to certain cereal prolamins, rye, barley 
and oats. It refers to the combined gliadin (prolamin) and glutenin fraction of wheat and 
displays unique structure building properties, three-dimensional protein network-forming 
properties being utilized in baking applications to create viscoelastic dough matrices, includes 
water binding and viscosity yielding, which make gluten a widely used food additive. They are 
highly resistant to hydrolysis mediated by proteases of the human gastrointestinal tract. Large 
gluten peptides as gliadin escape gastric digestion and accumulate in the small intestine. These 
characteristics could help in breaking the tolerance to this food antigen, when the immune 
system is activated, as can happen during an enteric infection, affect the intestinal permeability 
and modify the gut microbial activity. Undigested gluten containing carbohydrates entering the 
colon may be digested within the colon by the colonic bacterial flora, leading to fermentation 
and an increased in colonic gas, causing bloating and excess flatus. Celiac disease (CD) is a 
common immune-mediated enteropathy, which occurs following exposure to gluten in 
genetically susceptible individuals.   
Aim of the study. The purpose of the study is to determine the link between gluten and celiac 
disease by studying the protein properties of gluten.  
Materials and methods. The study was performed on 7798 persons aged 6 years or older. 
Serum samples from all participants were tested for immunoglobulin A (IgA) tissue 
transglutaminase antibodies. Based on the results about prior diagnosis of CD and use of a 
gluten-free diet (GFD). CD was defined as having either double-positive serology or other 
health-care professional and being on a GFD (reported clinical diagnosis of CD).  
